IRVINE, Calif.--(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today that Radius PCG™, a portable real-time capnograph with wireless Bluetooth® connectivity, has received FDA 510(k) clearance.

With the addition of Imprivata Medical Device Access to Masimo Root and Iris Gateway, hospitals gain access to an even more powerful patient monitoring and hospital automation solution designed to ...

Masimo announced U.S. Food and Drug Administration 510(k) clearance for the Root patient monitoring and connectivity platform. The platform includes a built-in connectivity gateway through Iris for ...

In 2014, Masimo introduced Root®, an intuitive open architecture patient monitoring and connectivity platform designed to speed the pace of innovation and reduce the cost of care. Masimo is also ...

Now Available for Both Cerebral and Somatic Applications and for All Patient Populations, O3’s Delta Hemoglobin Parameters Offer Clinicians Additional Insight Into Changes in Tissue Oxygen Saturation ...

Irvine, California-based Masimo, makers of a suite of non-invasive patient monitoring devices and sensors, has expanded the capabilities of its connected platform to allow physicians to view more data ...

The interoperability and connectivity of medical devices are widely recognised as important factors in helping hospitals achieve better patient data flow, synchronisation and harmonisation. “Hospitals ...

Masimo Corp., which is engaged in a bitter proxy battle, said an undisclosed bidder is offering between $850 million to $950 million for a majority stake in its consumer unit that it may spin out. The ...

Connected care company Masimo has landed and expanded FDA clearance for its O3 Regional Oximeter, for both somatic applications and monitoring changes in the cerebral hemoglobin. It specifically ...

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the CE marking for the pediatric indication for O3™ regional oximetry with the O3 pediatric sensor. Regional oximetry, ...